BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20533391)

  • 1. Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma.
    Johnsen HE; Bøgsted M; Klausen TW; Gimsing P; Schmitz A; Kjaersgaard E; Damgaard T; Voss P; Knudsen LM; Mylin AK; Nielsen JL; Björkstrand B; Gruber A; Lenhoff S; Remes K; Dahl IM; Fogd K; Dybkaer K; ;
    Cytometry B Clin Cytom; 2010 Sep; 78(5):338-47. PubMed ID: 20533391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of myeloma cells in the peripheral blood by flow cytometry.
    Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
    Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
    Moreau P; Robillard N; Avet-Loiseau H; Pineau D; Morineau N; Milpied N; Harousseau JL; Bataille R
    Haematologica; 2004 May; 89(5):547-51. PubMed ID: 15136217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.
    Ozsan GH; Dispenzieri A
    Expert Rev Clin Immunol; 2011 Jan; 7(1):65-73. PubMed ID: 21162651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
    Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
    Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
    Paiva B; Almeida J; Pérez-Andrés M; Mateo G; López A; Rasillo A; Vídriales MB; López-Berges MC; Miguel JF; Orfao A
    Cytometry B Clin Cytom; 2010 Jul; 78(4):239-52. PubMed ID: 20155853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
    Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
    Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach for plasma cell myeloma diagnosis by two-color flow cytometry based on kappa/lambda ratios of CD38-gated plasma cells.
    Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
    Int J Immunopathol Pharmacol; 2013; 26(2):479-83. PubMed ID: 23755763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of nine-color, 11-parameter flow cytometry for detection of plasma cell neoplasms: a comparison with bone marrow morphologic findings and concurrent M-protein studies in serum and urine.
    Behdad A; Ross CW; Jacques J; Kota U; Keren D; Stoolman L
    Am J Clin Pathol; 2014 Sep; 142(3):398-410. PubMed ID: 25125632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell neoplasms showing multilobulated nuclei.
    You E; Cho SY; Yang JJ; Lee HJ; Lee WI; Yoon HJ; Jeong KH; Lee J; Park TS
    Acta Haematol; 2013; 130(2):98-100. PubMed ID: 23548626
    [No Abstract]   [Full Text] [Related]  

  • 16. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual plasma cell analysis.
    Pojero F; Casuccio A; Parrino MF; Cardinale G; Colonna Romano G; Caruso C; Gervasi F
    Cytometry B Clin Cytom; 2015; 88(3):165-82. PubMed ID: 25529228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
    Foulk B; Schaffer M; Gross S; Rao C; Smirnov D; Connelly MC; Chaturvedi S; Reddy M; Brittingham G; Mata M; Repollet M; Rojas C; Auclair D; DeRome M; ; Weiss B; Sasser AK
    Br J Haematol; 2018 Jan; 180(1):71-81. PubMed ID: 29105742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
    Pope B; Brown R; Gibson J; Joshua D
    Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.
    Mishra J; Chopra A; Gogia A; Kumar R
    Indian J Pathol Microbiol; 2012; 55(1):130-2. PubMed ID: 22499328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.